1. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo;Franciosa, J.A.; Weber, K.T.; Levine, T.B.;Am Heart J,1982
2. Hemodynamic and clinical tachyphylaxis to prazosinmediated afterload reduction in severe chronic congestive heart failure;Packer, M.; Meller, J.; Gorlin, R.; Herman, M.V.;Circuktion,1979
3. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure;Elkayam, U.; Lejemtel, T.H.; Mathur, M.;Am J Cardiol,1979
4. Vascular versus myocardial selectivity in vitro of H154/82, a new dihydropyridine [Abstract]. Blood Vessek;Ljung, B.,1980
5. Interaction of the antihypertensive drug felodipine with calmodulin;Bostrom, S.-L.; Ljung, B.; M&rdh, S.; Forsen, S.; Thulin, E.;Natwe,1981